We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
+1.64%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
–
AUM
$109M
AUM Growth
-$2.59M
Cap. Flow
-$2.28M
Cap. Flow %
-2.09%
Top 10 Hldgs %
43.26%
Holding
70
New
6
Increased
9
Reduced
41
Closed
5

Top Buys

Rank Stock Value
1
GTLS
Chart Industries
GTLS
+$1.33M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$1.14M
3
TLGT
Teligent, Inc
TLGT
+$907K
4
VLO icon
Valero Energy
VLO
+$545K
5
CVX icon
Chevron
CVX
+$482K

Top Sells

Rank Stock Value
1
XENT
Intersect ENT, Inc
XENT
+$2.3M
2
HSTM icon
HealthStream
HSTM
+$891K
3
EOG icon
EOG Resources
EOG
+$703K
4
HAL icon
Halliburton
HAL
+$668K
5
OCLR
Oclaro Inc.
OCLR
+$552K

Sector Composition

Rank Sector Weight
1 Healthcare 48.27%
2 Technology 34.93%
3 Industrials 4.47%
4 Financials 3.02%
5 Miscellaneous 2.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCLR
1
DELISTED
Oclaro Inc.
OCLR
$7.62M 6.98%
882,831
-61,235
-6% -$552K
XENT
2
DELISTED
Intersect ENT, Inc
XENT
$6.99M 6.4%
224,372
-77,591
-26% -$2.3M
TLGT
3
DELISTED
Teligent, Inc
TLGT
$5.17M 4.74%
77,014
+12,386
+19% +$907K
NEO icon
4
NeoGenomics
NEO
$2.39B
$5.06M 4.63%
454,348
-6,454
-1% -$62.8K
SRGA
5
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$4.36M 3.99%
31,927
-519
-2% -$78.3K
FNSR
6
DELISTED
Finisar Corp
FNSR
$4.03M 3.69%
181,541
-3,002
-2% -$73.5K
OMCL icon
7
Omnicell
OMCL
$1.52B
$3.66M 3.36%
71,727
-1,240
-2% -$59.4K
AKRX
8
DELISTED
Akorn Inc
AKRX
$3.61M 3.31%
108,677
-9,160
-8% -$304K
CALD
9
DELISTED
Callidus Software, Inc.
CALD
$3.43M 3.14%
139,032
-2,404
-2% -$58.5K
CVLT icon
10
Commault Systems
CVLT
$5.82B
$3.29M 3.02%
54,156
-1,170
-2% -$69.9K
GIMO
11
DELISTED
Gigamon Inc.
GIMO
$3.14M 2.87%
74,402
-1,870
-2% -$76.3K
IDTI
12
DELISTED
Integrated Device Technology I
IDTI
$3.06M 2.81%
115,261
-2,265
-2% -$57.5K
LGND icon
13
Ligand Pharmaceuticals
LGND
$5.67B
$3M 2.75%
35,340
-593
-2% -$47K
NXTM
14
DELISTED
NxStage Medical Inc.
NXTM
$2.94M 2.7%
106,586
-2,960
-3% -$78.9K
SWKS icon
15
Skyworks Solutions
SWKS
$10.1B
$2.72M 2.5%
26,724
-600
-2% -$62.2K
ATRC icon
16
AtriCure
ATRC
$2.51B
$2.56M 2.35%
114,599
-2,295
-2% -$51.9K
PODD icon
17
Insulet
PODD
$9.95B
$2.47M 2.26%
44,833
-830
-2% -$45.3K
QRVO icon
18
Qorvo
QRVO
$8.49B
$2.26M 2.07%
31,930
-714
-2% -$49.8K
IMPV
19
DELISTED
Imperva, Inc.
IMPV
$2.17M 1.98%
49,883
-906
-2% -$41.3K
KTWO
20
DELISTED
K2M Group Holdings, Inc
KTWO
$2.08M 1.91%
98,256
-2,247
-2% -$52.1K
EGHT icon
21
8x8 Inc
EGHT
$290M
$2.02M 1.85%
149,670
-3,125
-2% -$42.6K
SUPN icon
22
Supernus Pharmaceuticals
SUPN
$2.57B
$1.83M 1.68%
45,831
+49
+0.1% +$2.12K
CYBR
23
DELISTED
CyberArk
CYBR
$1.78M 1.63%
43,448
-695
-2% -$29.4K
ENZ
24
DELISTED
Enzo Biochem, Inc.
ENZ
$1.74M 1.59%
165,727
-33,405
-17% -$371K
MXL icon
25
MaxLinear
MXL
$5.75B
$1.52M 1.4%
64,192
-1,020
-2% -$24.5K
1
2 3

Similar funds

OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return
PGA
Premia Global Advisors Coral Gables, Florida $57.9M AUM 2.91% 1-Year Est. Return
SCG
Saban Capital Group Los Angeles, California $59.5M AUM 3.83% 1-Year Est. Return
TCMV
Technology Crossover Management VI Menlo Park, California $59.6M AUM 18.81% 1-Year Est. Return
FCM
Farmstead Capital Management Ridgewood, New Jersey $49M AUM 10.57% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return

Kopp Investment Advisors's Q3 2017 Portfolio in Review

As of Q3 2017, Kopp Investment Advisors held 70 positions worth $109M, down 2.3% from $112M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Kopp Investment Advisors's Q3 2017 filing shows 6 new, 9 increased, 41 reduced and 5 closed positions. Its largest new stake was Chart Industries: 37,881 shares worth $1.49M. The largest sale was Intersect ENT, Inc, an estimated $2.3M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 49% a quarter earlier, followed by Technology and Industrials.

  • Kopp Investment Advisors's largest Q3 2017 buy was Chart Industries: 37,881 shares worth $1.49M.
  • Kopp Investment Advisors added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2017, an estimated $1.14M increase.
  • Kopp Investment Advisors's biggest Q3 2017 reduction was Intersect ENT, Inc, cutting an estimated $2.3M.
  • Kopp Investment Advisors fully exited HealthStream in Q3 2017, selling an estimated $891K.
  • Kopp Investment Advisors's ten largest holdings make up 43% of its $109M portfolio in Q3 2017.
  • Kopp Investment Advisors opened 6 new positions and closed 5 in Q3 2017.
  • Kopp Investment Advisors's portfolio value fell 2.3% quarter-over-quarter to $109M.

Based on Kopp Investment Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.